These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12470255)

  • 21. Recent trends in library design: 'rational design' revisited.
    Schnur DM
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virtual compound screening in drug discovery.
    Stumpfe D; Ripphausen P; Bajorath J
    Future Med Chem; 2012 Apr; 4(5):593-602. PubMed ID: 22458679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR-based methods and strategies for drug discovery.
    Salvatella X; Giralt E
    Chem Soc Rev; 2003 Nov; 32(6):365-72. PubMed ID: 14671791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methods for combinatorial and parallel library design.
    Schnur DM; Beno BR; Tebben AJ; Cavallaro C
    Methods Mol Biol; 2011; 672():387-434. PubMed ID: 20838978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ID NMR Methods in ligand-receptor interactions.
    Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ
    Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NMR assignment and structural characterization of the fatty acid binding protein from the flight muscle of Locusta migratoria.
    Lücke C; Kizilbash N; van Moerkerk HT; Veerkamp JH; Hamilton JA
    J Biomol NMR; 2003 Apr; 25(4):355-6. PubMed ID: 12766397
    [No Abstract]   [Full Text] [Related]  

  • 28. Library design for fragment based screening.
    Schuffenhauer A; Ruedisser S; Marzinzik AL; Jahnke W; Blommers M; Selzer P; Jacoby E
    Curr Top Med Chem; 2005; 5(8):751-62. PubMed ID: 16101415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure-based generation of viable leads from small combinatorial libraries.
    Laird ER; Blake JF
    Curr Opin Drug Discov Devel; 2004 May; 7(3):354-9. PubMed ID: 15216940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of small molecule libraries for NMR screening and other applications in drug discovery.
    Jacoby E; Davies J; Blommers MJ
    Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theory and applications of NMR-based screening in pharmaceutical research.
    Lepre CA; Moore JM; Peng JW
    Chem Rev; 2004 Aug; 104(8):3641-76. PubMed ID: 15303832
    [No Abstract]   [Full Text] [Related]  

  • 32. NMR in the acceleration of drug discovery.
    Sem DS; Pellecchia M
    Curr Opin Drug Discov Devel; 2001 Jul; 4(4):479-92. PubMed ID: 11727313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug screening strategy for human membrane proteins: from NMR protein backbone structure to in silica- and NMR-screened hits.
    Lindert S; Maslennikov I; Chiu EJ; Pierce LC; McCammon JA; Choe S
    Biochem Biophys Res Commun; 2014 Mar; 445(4):724-33. PubMed ID: 24525125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
    Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
    J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
    Langer T; Krovat EM
    Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NMR-based approaches for lead discovery.
    Wyss DF; McCoy MA; Senior MM
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):630-47. PubMed ID: 12197321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RAMPED-UP NMR: multiplexed NMR-based screening for drug discovery.
    Zartler ER; Hanson J; Jones BE; Kline AD; Martin G; Mo H; Shapiro MJ; Wang R; Wu H; Yan J
    J Am Chem Soc; 2003 Sep; 125(36):10941-6. PubMed ID: 12952475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Applications of NMR to structure-based drug design in structural genomics.
    Powers R
    J Struct Funct Genomics; 2002; 2(2):113-23. PubMed ID: 12836668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.